| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-076 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
| filingDate |
2010-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2017-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101730504-B1 |
| titleOfInvention |
Use of lanostane and poria extract in treating diabetes |
| abstract |
Compositions for treating diabetes are provided herein. This composition contains a Ranostene compound as an active ingredient. Appropriate materials of pyrano stain compounds Poria cocos extract from metabolite, sclerotia or Poria cocos (Poria cocos (Schw) Wolf). The extract of Bombyx mori extract contains 1-60% of the lanosthenate compounds by weight of the extract, and does not contain ekoranostane. |
| priorityDate |
2009-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |